EMBL: EBI Industry Workshop: Computational Approaches for Rare Disease Drug Discovery and Development
We’re looking forward to taking part in this upcoming EMBL: EBI industry workshop focused on the latest computational approaches being used in the development of treatments for rare conditions.
If you’re attending and would like to learn more about the cutting-edge AI and ML techniques being used to drive forward the discovery and translation of rare disease treatments, we’d recommend joining our Director of Therapeutic Technology, Ian Roberts, PhD, for his presentation on this topic – timings TBC.
During the session he will share case study evidence of this AI-powered approach in action and will explore the following areas:
- Overview of our AI-driven drug discovery platform, Healnet.
- How Healx combines AI with drug discovery expertise to find novel treatments for rare conditions.
- The use of AI in making drug development faster and more efficient and its role in identifying potential opportunities to redevelop existing drugs.
- Case study evidence of the success to date of this approach.
We hope to see you at the workshop! If you aren’t attending but would like to learn more about our work, please contact us for more information.